LUX Biosciences
Jersey City, US
Founders & leadership
AC
A. Clarke AtwellExecutive
EA
Eddy AngladeExecutive
Board
DS
David SchnellBoard director
LG
Lutz GiebelBoard director
DG
David GuyerBoard director
AB
Axel BolteBoard director
TD
Thomas DyrbergBoard director
PC
Paul ChaneyBoard director
DM
Dean MitchellBoard director
Reported raises · per SEC filings
Form D private placements$16M disclosed across 1 round · 2012
▶$16MraisedMar 2012 · 8 investors · BiotechnologyRule 506(b)
▶$16MraisedMar 2012 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchnellDirector
- A. Clarke AtwellExecutive Officer
- Eddy AngladeExecutive Officer
- Lutz GiebelDirector
- David GuyerDirector
- Paul ChaneyDirector
- Axel BolteDirector
- Thomas DyrbergDirector
- Dean MitchellDirector
- Offering amount
- $17.1M
- Amount sold
- $16M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has LUX Biosciences raised?
- LUX Biosciences has disclosed $16M raised across 1 round.
- Where is LUX Biosciences headquartered?
- LUX Biosciences is headquartered in Jersey City, US.